Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > tradeable warrants

<< Previous

Bullboard Posts

Next >>

Comment by 99942Apophison Oct 19, 2023 11:16am

218 Views

Post# 35690888

RE:RE:RE:RE:RE:RE:RE:RE:RE:tradeable warrants

Rumpl3StiltSkin honestly at this point in time I can't see any problem with warrants, these warrants are as solid as are the shares. BTD approval is in my opinion about to occur no doubts and no apprehension. There seems to be some people who are looking very hard at what could go wrong instead of what is going right.

First clue Dr.Kaouthar Lbiati awarded 300,000 option shares
Second clue Non-GLP toxicity analysis for Brain Cancer
Third clue 8 year shelf life for lead drug Ruvidar
Fourth clue US patent for Enhanced Immunotherapy
Fifth clue working through Pre-BTDs toward actual BTD

Onward and upward

<< Previous

Bullboard Posts

Next >>

Nvidia reports record revenue in Q3